We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Cytokinetics
CYTK
$11B
| $9.84M | 0.01% |
178,980
+157,755
| +743% | +$6.5M |
|
902
Xponential Fitness
XPOF
$265M
| $9.81M | 0.01% |
1,259,011
+151,506
| +14% | +$1.38M |
|
903
Collegium Pharmaceutical
COLL
$1.14B
| $9.76M | 0.01% |
279,013
+142,292
| +104% | +$4.95M |
|
904
PTC Therapeutics
PTCT
$6.37B
| $9.68M | 0.01% |
157,739
-380,037
| -71% | -$19.8M |
|
905
Dream Finders Homes
DFH
$1.46B
| $9.67M | 0.01% |
373,218
-119,720
| -24% | -$3.29M |
|
906
Atkore
ATKR
$2.59B
| $9.51M | 0.01% |
151,623
+78,592
| +108% | +$5.12M |
|
907
iShares MSCI South Korea ETF
EWY
$22.7B
| $9.49M | 0.01% |
+118,447
| New | +$8.82M |
|
|
TIGR
908
UP Fintech Holding
TIGR
$845M
| $9.43M | 0.01% |
883,610
-53,427
| -6% | -$573K |
|
909
TransUnion
TRU
$14.8B
| $9.42M | 0.01% |
112,452
-306,352
| -73% | -$27.8M |
|
|
CMRC
910
Commerce.com Inc Series 1
CMRC
$224M
| $9.42M | 0.01% |
1,887,521
-148,435
| -7% | -$714K |
|
911
Crescent Energy
CRGY
$3.72B
| $9.42M | 0.01% |
1,055,773
+1,027,970
| +3,697% | +$9.34M |
|
912
Kontoor Brands
KTB
$4.62B
| $9.4M | 0.01% |
117,794
-179,108
| -60% | -$12.8M |
|
|
913
CALL
Eli Lilly
LLY
$1.07T
| $9.38M | 0.01% |
12,300
+8,400
| +215% | +$6.25M |
|
914
Brookdale Senior Living
BKD
$3.62B
| $9.35M | 0.01% |
1,104,397
-2,302,303
| -68% | -$17.5M |
|
915
Verastem
VSTM
$532M
| $9.32M | 0.01% |
1,055,389
+787,056
| +293% | +$5.86M |
|
916
PUT
Moderna
MRNA
$21.5B
| $9.29M | 0.01% |
+359,600
| New | +$10M |
|
917
Capital Group Growth ETF
CGGR
$23.5B
| $9.27M | 0.01% |
+211,035
| New | +$8.91M |
|
|
DEFT
918
Defi Technologies
DEFT
$153M
| $9.25M | 0.01% |
4,384,356
+2,461,204
| +128% | +$6.37M |
|
919
argenx
ARGX
$57.4B
| $9.24M | 0.01% |
12,525
-165,199
| -93% | -$109M |
|
920
Cogent Biosciences
COGT
$6.79B
| $9.23M | 0.01% |
+642,479
| New | +$7.61M |
|
921
Trimble
TRMB
$12.3B
| $9.22M | 0.01% |
112,900
-600
| -0.5% | -$48.9K |
|
|
GOOS
922
Canada Goose Holdings
GOOS
$868M
| $9.14M | 0.01% |
662,727
-458,229
| -41% | -$5.94M |
|
923
Ferrovial N.V. Ordinary Shares
FER
$45.3B
| $9.12M | 0.01% |
157,194
-11,194
| -7% | -$603K |
|
|
WYFI
924
WhiteFiber Inc
WYFI
$912M
| $9.11M | 0.01% |
+335,125
| New | +$6.55M |
|
925
Agios Pharmaceuticals
AGIO
$2.16B
| $9.1M | 0.01% |
226,824
-457,845
| -67% | -$17.2M |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.